Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.
Mandate

Vinge advises Fidelio Capital in connection with the acquisition of Veterinary Orthopedic Implants, Inc.

May 22, 2020 Banking and Finance M&A EU, Competition and Regulatory

Vinge has advised Fidelio Capital on the acquisition of Veterinary Orthopedic Implants, Inc (“VOI”).

VOI is a fast-growing US company within the market for veterinary orthopedic implants and instruments.

Vinge’s team consisted of, among others, Jonas Bergström, Manne Bergström, Johanna Wiberg and Carl-Fredrik Wachtmeister (M&A/Corporate), Albert Wållgren and Axel Jansson (Banking and Finance), Johan Karlsson, Sebastian Örndahl and Lisa Malmborg (Competition) and Christoffer Widström (VDR-specialist).

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

 Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

 Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

 Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026